IBSA PHARMA INC

IBSA PHARMA INC. is a subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. Located in Parsippany, New Jersey, IBSA USA focuses on improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA USA also markets Licart™ (diclofenac epolamine) topical, a nonsteroidal anti-inflammatory drug (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. The company is committed to providing therapeutic alternatives to patients. IBSA USA prioritizes patient well-being and strives to deliver innovative treatments. Their commitment to quality and responsibility is reflected in their parent company's philosophy, which centers around four pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, please visit each brand’s respective website.